Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma

Renumathy Dhanasekaran, Jayant A. Talwalkar

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Hepatocellular carcinoma is the most common primary liver cancer in patients with cirrhosis and is the leading cause of mortality in these patients. Despite existence of robust clinical practice guidelines for surveillance, diagnosis, and management for hepatocellular carcinoma (HCC), the quality of care received by patients with HCC has been inconsistent. Several studies have reported disappointingly low surveillance rates in high-risk groups which likely contribute to most HCC cases being diagnosed at advanced stages. There is also data from large studies showing that significant under-referral to specialists and delay in initiation of treatment are linked to poor clinical outcomes. Given above circumstances, it is very important to perform studies which can identify areas in need of improvement in the care processes of HCC and design interventions to enhance quality of care. Unfortunately, data on validated quality indicators and quality metrics for HCC are non-existent. In this article, we review the existing literature pertaining to this issue and identify areas that need further research.

Original languageEnglish (US)
Article number34
JournalCurrent Gastroenterology Reports
Volume17
Issue number9
DOIs
StatePublished - Sep 6 2015

Fingerprint

Quality of Health Care
Hepatocellular Carcinoma
Fibrosis
Neoplasms
Liver Neoplasms
Practice Guidelines
Referral and Consultation
Mortality
Research

Keywords

  • Cirrhosis
  • HCC
  • Hepatitis
  • Quality
  • Specialist
  • Surveillance
  • Underutilization

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma. / Dhanasekaran, Renumathy; Talwalkar, Jayant A.

In: Current Gastroenterology Reports, Vol. 17, No. 9, 34, 06.09.2015.

Research output: Contribution to journalArticle

Dhanasekaran, Renumathy ; Talwalkar, Jayant A. / Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma. In: Current Gastroenterology Reports. 2015 ; Vol. 17, No. 9.
@article{956c04e4216b48c08bfcbc6b0705867a,
title = "Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma",
abstract = "Hepatocellular carcinoma is the most common primary liver cancer in patients with cirrhosis and is the leading cause of mortality in these patients. Despite existence of robust clinical practice guidelines for surveillance, diagnosis, and management for hepatocellular carcinoma (HCC), the quality of care received by patients with HCC has been inconsistent. Several studies have reported disappointingly low surveillance rates in high-risk groups which likely contribute to most HCC cases being diagnosed at advanced stages. There is also data from large studies showing that significant under-referral to specialists and delay in initiation of treatment are linked to poor clinical outcomes. Given above circumstances, it is very important to perform studies which can identify areas in need of improvement in the care processes of HCC and design interventions to enhance quality of care. Unfortunately, data on validated quality indicators and quality metrics for HCC are non-existent. In this article, we review the existing literature pertaining to this issue and identify areas that need further research.",
keywords = "Cirrhosis, HCC, Hepatitis, Quality, Specialist, Surveillance, Underutilization",
author = "Renumathy Dhanasekaran and Talwalkar, {Jayant A.}",
year = "2015",
month = "9",
day = "6",
doi = "10.1007/s11894-015-0459-8",
language = "English (US)",
volume = "17",
journal = "Current Gastroenterology Reports",
issn = "1522-8037",
publisher = "Current Medicine Group",
number = "9",

}

TY - JOUR

T1 - Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma

AU - Dhanasekaran, Renumathy

AU - Talwalkar, Jayant A.

PY - 2015/9/6

Y1 - 2015/9/6

N2 - Hepatocellular carcinoma is the most common primary liver cancer in patients with cirrhosis and is the leading cause of mortality in these patients. Despite existence of robust clinical practice guidelines for surveillance, diagnosis, and management for hepatocellular carcinoma (HCC), the quality of care received by patients with HCC has been inconsistent. Several studies have reported disappointingly low surveillance rates in high-risk groups which likely contribute to most HCC cases being diagnosed at advanced stages. There is also data from large studies showing that significant under-referral to specialists and delay in initiation of treatment are linked to poor clinical outcomes. Given above circumstances, it is very important to perform studies which can identify areas in need of improvement in the care processes of HCC and design interventions to enhance quality of care. Unfortunately, data on validated quality indicators and quality metrics for HCC are non-existent. In this article, we review the existing literature pertaining to this issue and identify areas that need further research.

AB - Hepatocellular carcinoma is the most common primary liver cancer in patients with cirrhosis and is the leading cause of mortality in these patients. Despite existence of robust clinical practice guidelines for surveillance, diagnosis, and management for hepatocellular carcinoma (HCC), the quality of care received by patients with HCC has been inconsistent. Several studies have reported disappointingly low surveillance rates in high-risk groups which likely contribute to most HCC cases being diagnosed at advanced stages. There is also data from large studies showing that significant under-referral to specialists and delay in initiation of treatment are linked to poor clinical outcomes. Given above circumstances, it is very important to perform studies which can identify areas in need of improvement in the care processes of HCC and design interventions to enhance quality of care. Unfortunately, data on validated quality indicators and quality metrics for HCC are non-existent. In this article, we review the existing literature pertaining to this issue and identify areas that need further research.

KW - Cirrhosis

KW - HCC

KW - Hepatitis

KW - Quality

KW - Specialist

KW - Surveillance

KW - Underutilization

UR - http://www.scopus.com/inward/record.url?scp=84938587897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938587897&partnerID=8YFLogxK

U2 - 10.1007/s11894-015-0459-8

DO - 10.1007/s11894-015-0459-8

M3 - Article

VL - 17

JO - Current Gastroenterology Reports

JF - Current Gastroenterology Reports

SN - 1522-8037

IS - 9

M1 - 34

ER -